Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
An estimated 21 million American women experience BV
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
It is an application to automate statistical analysis and reporting for clinical research.
The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve
Subscribe To Our Newsletter & Stay Updated